The European Medicines Agency’s (EMA) expert committee, the CHMP, has given a positive opinion for 13 news drugs, following the committee’s February monthly meeting. This brings the year’s total up to 20 new drugs pending official approval, while 17 existing drugs can await indication expansions.
The Committee for Medicinal Products for Human Use has first given a positive opinion to Immunocore Ireland’s drug Kimmtrak (tebentafusp), a treatment for the rare eye cancer type known as uveal melanoma. This is a difficult to treat condition, as it spreads quickly and has proven resistent to existing treatments, and the drug was therefore reviewed under the CHMP’s accelerated assessment program.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Director Global Engineering 
Director for innovative pre-clinical testing unit 
Quality System Manager 
Scientific Writer 
Clinical Project Manager 
(Senior) Drug Substance Specialist 
Communications Consultant 
Senior Project Manager (GMP - Life Science) 
Senior Manager, Clinical Trial Budget 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Cell Culture Scientist/Senior Scientist 
Account Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Client Talent Acquisition Specialist 
SAP System Specialist (Product Supply) – Business Application Services